4.8 Article

A cross-chiral RNA polymerase ribozyme

Journal

NATURE
Volume 515, Issue 7527, Pages 440-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature13900

Keywords

-

Funding

  1. NASA [NNX10AQ91G]
  2. Simons Foundation [287624]
  3. National Institutes of Health [F32 GM101741]
  4. NASA [125589, NNX10AQ91G] Funding Source: Federal RePORTER

Ask authors/readers for more resources

Thirty years ago it was shown that the non-enzymatic, template-directed polymerization of activated mononudeotides proceeds readily in a homochiral system, but is severely inhibited by the presence of the opposing enantiomerl. This finding poses a severe challenge for the spontaneous emergence of RNA-based life, and has led to the suggestion that either RNA was preceded by some other genetic polymer that is not subject to chiral inhibition(2) or chiral symmetry was broken through chemical processes before the origin of RNA-based life(3,4). Once an RNA enzyme arose that could catalyse the polymerization of RNA, it would have been possible to distinguish among the two enantiomers, enabling RNA replication and RNA-based evolution to occur. It is commonly thought that the earliest RNA polymerase and its substrates would have been of the same handedness, but this is not necessarily the case. Replicating D- and L-RNA molecules may have emerged together, based on the ability of structured RNAs of one handedness to catalyse the templated polymerization of activated mononudeotides of the opposite handedness. Here we develop such a cross-chiral RNA polymerase, using in vitro evolution starting from a population of random-sequence RNAs. The El-RNA enzyme, consisting of 83 nucleotides, catalyses the joining of L-mono- or oligonudeotide substrates on a complementary L-RNA template, and similar behaviour occurs for the L-enzyme with El-substrates and a El-template. Chiral inhibition is avoided because the 10(6)-fold rate acceleration of the enzyme only pertains to cross-chiral substrates. The enzyme's activity is sufficient to generate full-length copies of its enantiomer through the templated joining of 11 component oligonudeotides.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available